Cargando…
ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection
Migratory dendritic cells expressing CD103 are the targets for mucosal vaccines. These belong to either of two lineage-restricted subsets, cDC1 or cDC2 cells, which have been linked to priming of functionally distinct CD4 T cells. However, recent studies have identified plasticity in cDC2 cells with...
Autores principales: | Arabpour, Mohammad, Lebrero-Fernandez, Cristina, Schön, Karin, Strömberg, Anneli, Börjesson, Vanja, Lahl, Katharina, Ballegeer, Marlies, Saelens, Xavier, Angeletti, Davide, Agace, William, Lycke, Nils |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259495/ https://www.ncbi.nlm.nih.gov/pubmed/35418673 http://dx.doi.org/10.1038/s41385-022-00510-1 |
Ejemplares similares
-
Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity
por: Omokanye, Ajibola, et al.
Publicado: (2022) -
ADP-ribosylation of arginine
por: Laing, Sabrina, et al.
Publicado: (2010) -
Reversing ADP-ribosylation
por: Moeller, Giuliana Katharina, et al.
Publicado: (2017) -
An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis
por: Arabpour, Mohammad, et al.
Publicado: (2022) -
Arginine-Specific Mono ADP-Ribosylation In Vitro of Antimicrobial Peptides by ADP-Ribosylating Toxins
por: Castagnini, Marta, et al.
Publicado: (2012)